QuiVad

Home / Funds / GSA Capital Partners LLP

GSA Capital Partners LLP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Nyesa Valores Corporacion, S.A.Spain1.56%August 11, 2026
Tessellis SPAItaly1.38%August 12, 2026
Tobii ABSweden1.31%July 17, 2026
Oncopeptides ABSweden1.30%August 11, 2026
2020 BulkersNorway1.24%August 13, 2026
Valneva SEFrance1.21%July 21, 2026
Hexagon CompositesNorway1.08%August 13, 2026
Powercell Sweden AB (publ)Sweden0.91%July 9, 2026
RaySearch Laboratories AB (publ)Sweden0.90%August 13, 2026
OssDsign ABSweden0.81%June 1, 2026
Hilbert Group AB (publ)Sweden0.79%August 6, 2026
Hansa Biopharma ABSweden0.60%August 6, 2026
Solutions 30 SEFrance0.60%July 22, 2026
Bertrandt AktiengesellschaftGermany0.53%September 28, 2017
S&T AGGermany0.52%November 14, 2017
ADVA Optical Networking SEGermany0.50%October 26, 2017
CellectisFrance0.50%February 7, 2023
Hamborner Reit AGGermany0.50%October 13, 2017
Nobia ABSweden0.50%June 12, 2026
Thor Medical ASANorway0.50%June 24, 2026
Trevi - Finanziaria Industriale SPAItaly0.50%August 11, 2026
Tubacex, S.A.Spain0.50%July 10, 2026

History of disclosures

4370 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
March 12, 2026Dicot Pharma ABSweden0.69%still open
March 9, 2026Hexagon CompositesNorway1.80%March 10, 2026
March 9, 2026Dicot Pharma ABSweden0.78%still open
March 6, 2026Powercell Sweden AB (publ)Sweden0.51%still open
March 6, 2026Alfen N.V.Netherlands0.48%still open
March 5, 2026Tobii ABSweden1.60%still open
March 4, 2026Hexagon CompositesNorway1.72%March 9, 2026
March 4, 2026Dicot Pharma ABSweden0.80%still open
March 4, 2026Alfen N.V.Netherlands0.55%still open
March 4, 2026Salmon Evolution ASANorway0.50%May 4, 2026
March 3, 2026OssDsign ABSweden0.60%still open
February 27, 2026Alfen N.V.Netherlands0.69%still open
February 25, 2026Hexagon CompositesNorway1.60%March 2, 2026
February 25, 2026BICO Group ABSweden0.50%still open
February 25, 2026Hansa Biopharma ABSweden0.50%still open
February 24, 2026Alfen N.V.Netherlands0.79%still open
February 24, 2026Dicot Pharma ABSweden0.70%still open
February 20, 2026Hexagon CompositesNorway1.52%February 23, 2026
February 20, 2026Tobii ABSweden1.51%still open
February 20, 2026Solutions 30 SEFrance0.61%still open
February 19, 2026Alfen N.V.Netherlands0.87%still open
February 18, 2026EkinopsFrance0.50%August 6, 2026
February 17, 2026MilDef Group ABSweden0.50%still open
February 16, 2026Dicot Pharma ABSweden0.61%still open
February 16, 2026OssDsign ABSweden0.50%still open
February 13, 2026Hexagon CompositesNorway1.42%February 16, 2026
February 13, 2026Tobii ABSweden1.40%still open
February 13, 2026Alfen N.V.Netherlands0.96%still open
February 11, 2026Hansa Biopharma ABSweden0.50%still open
February 10, 2026Hexagon CompositesNorway1.32%February 11, 2026
February 10, 2026Tobii ABSweden1.31%still open
February 6, 2026Valneva SEFrance0.60%May 6, 2026
February 6, 2026Dicot Pharma ABSweden0.51%still open
February 5, 2026Hexagon CompositesNorway1.23%February 9, 2026
February 2, 2026Hexagon CompositesNorway1.11%February 3, 2026
January 29, 2026Valneva SEFrance0.59%May 6, 2026
January 21, 2026Hexagon CompositesNorway1.01%January 22, 2026
January 16, 2026Alfen N.V.Netherlands1.09%still open
January 14, 2026Hexagon CompositesNorway0.91%January 15, 2026
January 13, 2026Tobii ABSweden1.22%still open
January 13, 2026Hunter GroupNorway0.83%January 14, 2026
January 9, 2026Hexagon CompositesNorway0.82%January 12, 2026
January 8, 2026Tobii ABSweden1.12%still open
January 5, 2026Hexagon CompositesNorway0.70%January 6, 2026
January 2, 2026Hunter GroupNorway1.61%January 13, 2026
December 31, 2025Alfen N.V.Netherlands1.10%still open
December 30, 2025GenfitFrance0.49%January 2, 2026
December 23, 2025Hexagon CompositesNorway0.60%December 29, 2025
December 19, 2025GenfitFrance0.50%January 2, 2026
December 18, 2025Hexagon CompositesNorway0.50%December 19, 2025

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GSA Capital Partners LLP, data as at August 13, 2026, https://www.quivad.com/detenteur/gsa-capital-partners-llp?page=4